Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
GRFS · against 221 other Healthcare companies of similar size
Ranked #196 of 222 · scores higher than 12% of peers · safety percentile 16
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)19 peers with a safety percentile of 10–19, including GRFS · Click a bar to see the companies
Mainly because of its debt / equity and beta, which are weaker than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | GRFS | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 213 reported | 1.17× | 0.25× | 12% | 33% | |
| BetaLower is better · 221 reported | 1.19 | 0.55 | 19% | 33% | |
| Current ratioHigher is better · 212 reported | 2.37× | 2.76× | 44% | 33% |
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 5.6B USD | 100 | 53 | |
| 1 | 6.6B USD | 100 | 45 | |
| 3 | 3.6B USD | 99 | ||
| 4 | 10.1B EUR (≈$11.1B) | 99 | ||
| 5 | 3.1B EUR (≈$3.4B) | 99 | 100 | |
| 192 | 10.0B USD | 18 | 64 | |
| 193 | 4.7B GBP (≈$6.1B) |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score
| 17 |
| 49 |
| 194 | 379.9B INR (≈$4.6B) | 17 | 55 |
| 195 | 8.7B USD | 16 | 26 |
| 196 | 5.8B USD | 16 | 64 |
| 197 | 28.9B CNY (≈$4.0B) | 15 | 51 |
| 198 | 9.3B USD | 15 | 64 |
| 199 | 3.1B EUR (≈$3.4B) | 14 | 42 |
| 200 | 6.0B USD | 13 | 32 |